Radiation as Adjuvant to Immunotherapy: Optimizing Regimens and Sites

When:  Sep 27, 2016 from 4:45 PM to 6:00 PM (ET)

Radiation as Adjuvant to Immunotherapy: Optimizing Regimens and Sites

September 27, 2016
Boston Convention and Exhibition Center • Boston, Massachusetts

Presented by the American Society for Radiation Oncology (ASTRO) in collaboration with the Society for Immunotherapy of Cancer

This joint session was part of the 2016 ASTRO Annual Meeting.

Participants at this session learned the rationale for combining specific regimens of radiation therapy with immunotherapy, as well as the controversies surrounding the optimal treatment sites for radiotherapy when used as an adjuvant to immunotherapy treatment. Attendees were prepared to apply this knowledge in analyzing and choosing treatment combinations and radiation regimens. A panel discussion gave participants an opportunity to ask questions of experts on these topics.

Moderator
Silvia Formenti, MD, FASTRO – Weill Cornell Medical College

Session Speakers and Topics

4:45–5:05 p.m. Role of Target/Site of Radiotherapy When Used as an Adjuvant to Immunotherapy
William McBride, PhD DSc – University of California, Los Angeles
5:05–5:25 p.m. Role of Dose/Fractionation of Radiotherapy When Used as as an Adjuvant to Immunotherapy
Sandra DeMaria, MD – Weill Cornell Medical College
5:25–5:45 p.m. Results From a Clinical Trial Exploring Different Doses/Fractionations of Radiotherapy
James W. Welsh, MD MD Anderson Cancer Center
5:45–6:00 p.m. Panel Discussion
All Session Faculty

Find more information here.

Location

Boston Convention and Exhibition Center
Boston, Massachusetts